All In MedTech

Device Trial Radar · NCT01268345

AST Clinical Investigation

Last checked: Nov 20, 2026Latest source record: Dec 30, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

Oct 2010

Primary completion

Dec 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Andon Medical Co.,LtdNot on our public-company list
Sponsor type
Industry
First posted
Dec 30, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 21 years, up to 78 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.

Conditions

  • Diabetes

Interventions

  • blood glucose monitorDevice

    Blood glucose monitor is used to monitor the blood glucose level of the human-being

  • blood glucose monitorDevice

    Blood glucose monitor is used to monitor the blood glucose level of the human-being.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. blood glucose valueTime frame: 5 seconds

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tianjin Hexi Ruijing metabolism hospital

    Tianjin, Tianjin Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.